Literature DB >> 10070013

Nonsaturable entry of neuropeptide Y into brain.

A J Kastin1, V Akerstrom.   

Abstract

Neuropeptide Y (NPY) is found and is active both in the periphery and brain, but its crossing of the blood-brain barrier (BBB) in either direction has not been measured. We used multiple time-regression analysis to determine that radioactively labeled NPY injected intravenously entered the brain much faster than albumin, with an influx constant of 2.0 x 10(-4) ml. g. -1. min-1. However, this rate of entry was not significantly changed by injection of 10 microgram/mouse of excess NPY, by leptin, or by food deprivation. HPLC showed that most of the NPY entering the brain was intact, and capillary depletion with and without washout showed that the NPY did not remain bound to endothelial cells or associated with vascular elements. Perfusion in a blood-free solution eliminated binding to serum proteins as an explanation for the lack of saturation. Efflux of labeled NPY from the brain occurred at the same rate as albumin, reflecting the normal rate of reabsorption of cerebrospinal fluid. Thus NPY can readily enter the brain from blood by diffusion across the BBB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10070013     DOI: 10.1152/ajpendo.1999.276.3.E479

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

Review 1.  Cytokine signaling modulates blood-brain barrier function.

Authors:  Weihong Pan; Kirsten P Stone; Hung Hsuchou; Vamshi K Manda; Yan Zhang; Abba J Kastin
Journal:  Curr Pharm Des       Date:  2011-11       Impact factor: 3.116

Review 2.  Concepts for biologically active peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2010-10       Impact factor: 3.116

Review 3.  Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides.

Authors:  Abba J Kastin; Weihong Pan
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 4.  Regulation of feeding-associated peptides and receptors by nicotine.

Authors:  M D Li; S L Parker; J K Kane
Journal:  Mol Neurobiol       Date:  2000 Aug-Dec       Impact factor: 5.590

5.  Non-specific binding and general cross-reactivity of Y receptor agonists are correlated and should importantly depend on their acidic sectors.

Authors:  M S Parker; R Sah; A Balasubramaniam; F R Sallee; O Zerbe; S L Parker
Journal:  Peptides       Date:  2010-11-30       Impact factor: 3.750

6.  The STEDMAN project: biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain.

Authors:  Lillian F Lien; Andrea M Haqq; Michelle Arlotto; Cris A Slentz; Michael J Muehlbauer; Ross L McMahon; James Rochon; Dianne Gallup; James R Bain; Olga Ilkayeva; Brett R Wenner; Robert D Stevens; David S Millington; Deborah M Muoio; Mark D Butler; Christopher B Newgard; Laura P Svetkey
Journal:  OMICS       Date:  2009-02

7.  Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats.

Authors:  Melanie Felies; Stephan von Hörsten; Reinhard Pabst; Heike Nave
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

8.  Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity.

Authors:  Lesley Baerts; Raf Brouns; Kaat Kehoe; Robert Verkerk; Sebastiaan Engelborghs; Peter Paul De Deyn; Dirk Hendriks; Ingrid De Meester
Journal:  Transl Stroke Res       Date:  2016-08-26       Impact factor: 6.829

9.  Distribution of peripherally injected peptide YY ([125I] PYY (3-36)) and pancreatic polypeptide ([125I] hPP) in the CNS: enrichment in the area postrema.

Authors:  Yvan Dumont; Emmanuel Moyse; Alain Fournier; Rémi Quirion
Journal:  J Mol Neurosci       Date:  2007-09-18       Impact factor: 3.444

10.  Circulating TGF-beta1 does not cross the intact blood-brain barrier.

Authors:  Abba J Kastin; Victoria Akerstrom; Weihong Pan
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.